ODP563 Breast Cancer With Liver Metastasis Responds Poorly to Fulvestrant-Based Combination Therapy and Chemotherapy

por Chien, Christine, Raghavendra, Akshara S, Tripathy, Debasish, Madak-Erdogan, Zeynep
Publicado 2022

Survival Outcomes in Patients With Hormone Receptor–Positive Metastatic Breast Cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy

por Mouabbi, Jason A., Singareeka Raghavendra, Akshara, Bassett, Roland L., Hassan, Amy, Tripathy, Debasish, Layman, Rachel M.
Publicado 2023

ODP647 Nuclear ERα and NAMPT Crosstalk in Metastatic Breast Tumors

por Mogol, Ayca, Chien, Christine, Zuo, Qianying, Singareeka Raghavendra, Akshara, Tripathy, Debu, Landesman, Yosef, Madak-Erdogan, Zeynep
Publicado 2022

Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies

por Mouabbi, Jason A., Raghavendra, Akshara Singareeka, Bassett, Roland L., Hassan, Amy, Tripathy, Debu, Layman, Rachel M.
Publicado 2022

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer

por Garber, Haven R., Raghavendra, Akshara Singareeka, Lehner, Michael, Qiao, Wei, Gutierrez-Barrera, Angelica M., Tripathy, Debu, Arun, Banu, Ibrahim, Nuhad K.
Publicado 2022

Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer

por Barcenas, Carlos H., Song, Juhee, Murthy, Rashmi K., Raghavendra, Akshara S., Li, Yisheng, Hsu, Limin, Carlson, Robert W., Tripathy, Debu, Hortobagyi, Gabriel N.
Publicado 2021

Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice

por Murthy, Rashmi K., Song, Juhee, Raghavendra, Akshara S., Li, Yisheng, Hsu, Limin, Hess, Kenneth R., Barcenas, Carlos H., Valero, Vicente, Carlson, Robert W., Tripathy, Debu, Hortobagyi, Gabriel N.
Publicado 2020

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer

por Singareeka Raghavendra, Akshara, Alameddine, Hala F., Andersen, Clark R., Selber, Jesse C., Brewster, Abenaa M., Barcenas, Carlos H., Caudle, Abigail S., Arun, Banu K., Tripathy, Debu, Ibrahim, Nuhad K.
Publicado 2021

The Impact of Treatment for Smoking on Breast Cancer Patients’ Survival

por Singareeka Raghavendra, Akshara, Kypriotakis, George, Karam-Hage, Maher, Kim, Seokhun, Jizzini, Mazen, Seoudy, Kareem S., Robinson, Jason D., Barcenas, Carlos H., Cinciripini, Paul M., Tripathy, Debu, Ibrahim, Nuhad K.
Publicado 2022

Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy

por Fujii, Takeo, Kogawa, Takahiro, Wu, Jimin, Sahin, Aysegul A, Liu, Dian D, Chavez-MacGregor, Mariana, Giordano, Sharon H, Raghavendra, Akshara, Murthy, Rushmy K, Tripathy, Debu, Shen, Yu, Yamal, Jose-Miguel, Ueno, Naoto T
Publicado 2017

Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment

por Liu, Shuying, Xie, Shelly M., Liu, Wenbin, Gagea, Mihai, Hanker, Ariella B., Nguyen, Nguyen, Raghavendra, Akshara Singareeka, Yang-Kolodji, Gloria, Chu, Fuliang, Neelapu, Sattva S., Hanash, Samir, Zimmermann, Johann, Arteaga, Carlos L., Tripathy, Debasish
Publicado 2023

Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment

por Liu, Shuying, Xie, Shelly M., Liu, Wenbin, Gagea, Mihai, Hanker, Ariella B., Nguyen, Nguyen, Singareeka Raghavendra, Akshara, Yang-Kolodji, Gloria, Chu, Fuliang, Neelapu, Sattva S., Marchese, Adriano, Hanash, Samir, Zimmermann, Johann, Arteaga, Carlos L., Tripathy, Debasish
Publicado 2023

LPTO-08. INTRATHECAL TRASTUZUMAB PLUS/MINUS IT TOPOTECAN FOR PATIENTS WITH HER2+ BREAST CANCER AND LEPTOMENINGEAL METASTASIS

por Trevino, Christopher R, Murthy, Rashmi K, Raghavendra, Akshara Singareeka, Loghin, Monica, Seligman, Christa, Ferguson, Sherise, Kamiya-Matsuoka, Carlos, Harrison, Rebecca, Sinicrope, Kaylyn D, Valero, Vicente, Tummala, Sudhakar, Hess, Kenneth, Tripathy, Debu, de Groot, John, O’Brien, Barbara
Publicado 2019

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

por Vijayaraghavan, Smruthi, Karakas, Cansu, Doostan, Iman, Chen, Xian, Bui, Tuyen, Yi, Min, Raghavendra, Akshara S., Zhao, Yang, Bashour, Sami I., Ibrahim, Nuhad K., Karuturi, Meghan, Wang, Jing, Winkler, Jeffrey D., Amaravadi, Ravi K., Hunt, Kelly K., Tripathy, Debu, Keyomarsi, Khandan
Publicado 2017

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

por Caswell-Jin, Jennifer L., McNamara, Katherine, Reiter, Johannes G., Sun, Ruping, Hu, Zheng, Ma, Zhicheng, Ding, Jie, Suarez, Carlos J., Tilk, Susanne, Raghavendra, Akshara, Forte, Victoria, Chin, Suet-Feung, Bardwell, Helen, Provenzano, Elena, Caldas, Carlos, Lang, Julie, West, Robert, Tripathy, Debu, Press, Michael F., Curtis, Christina
Publicado 2019

Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

por Caswell-Jin, Jennifer L., McNamara, Katherine, Reiter, Johannes G., Sun, Ruping, Hu, Zheng, Ma, Zhicheng, Ding, Jie, Suarez, Carlos J., Tilk, Susanne, Raghavendra, Akshara, Forte, Victoria, Chin, Suet-Feung, Bardwell, Helen, Provenzano, Elena, Caldas, Carlos, Lang, Julie, West, Robert, Tripathy, Debu, Press, Michael F., Curtis, Christina
Publicado 2019

Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases

por Kabraji, Sheheryar, Ni, Jing, Sammons, Sarah, Li, Tianyu, Van Swearingen, Amanda E.D., Wang, Yanzhi, Pereslete, Alyssa, Hsu, Liangge, DiPiro, Pamela J., Lascola, Chris, Moore, Heather, Hughes, Melissa, Raghavendra, Akshara S., Gule-Monroe, Maria, Murthy, Rashmi K., Winer, Eric P., Anders, Carey K., Zhao, Jean J., Lin, Nancy U.
Publicado 2023